The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury
Article in Biomedicine & Pharmacotherapy (June 2024)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney
Article in PLOS ONE (February 2023)
AMPK: The key to ischemia‐reperfusion injury
Article in Journal of Cellular Physiology (September 2022)